Study of Forced Degradation Behaviour of Brinzolamide Using LC–ESI–Q-TOF and In Silico Toxicity Prediction

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 461 citations

Pharmacy, Pharmaceutics, Toxicology +12

A Critical Assessment of the ICH Guideline on Photostability Testing of New Drug Substances and Products (Q1B): Recommendation for Revision

Steven W. Baertschi, Karen M. Alsante, Hanne Hjorth Tønnesen · Journal of Pharmaceutical Sciences · 2010 · 107 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +11

Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008

Ann McMahon, Robert G. Pratt, Tarek A. Hammad et al. · Pharmacoepidemiology and Drug Safety · 2010 · 61 citations

Pharmacy, Pharmacology, Toxicology +13

Ocular Pharmacokinetics of Dorzolamide and Brinzolamide After Single and Multiple Topical Dosing: Implications for Effects on Ocular Blood Flow

Rajendra S. Kadam, Gajanan Jadhav, Miller J. Ogidigben et al. · Drug Metabolism and Disposition · 2011 · 39 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Enantiomeric Separation and Simulation Studies of Pheniramine, Oxybutynin, Cetirizine, and Brinzolamide Chiral Drugs on Amylose‐Based Columns

Imran Ali, Zeid A. ALOthman, Abdulrahman Al‐Warthan et al. · Chirality · 2014 · 34 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17